Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0000950170-25-048894

Options or other derivatives

  • Director acquired 36,979 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Civik Thomas Director 2025-03-31 Grant or award · Stock Option (Right to Buy) +36,979 $0.98 $36,239 36,979 D: show line 1 in the form
Loading xslF345X05/ownership.xml…